NASDAQ: SQLSeqll Inc Stock
$0.46-0.03 (-6.12%)
Updated Jun 2, 2023
SQL Price
$0.46
Fair Value Price
N/A
Market Cap
$6.42M
52 Week Low
$0.23
52 Week High
$2.40
P/E
-1.18x
P/B
1.52x
P/S
165.33x
PEG
N/A
Dividend Yield
N/A
Revenue
$31.18k
Earnings
-$4.88M
Gross Margin
97.8%
Operating Margin
-15,346.24%
Profit Margin
-15,637.3%
Debt to Equity
1
Operating Cash Flow
-$4M
Beta
1.47
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SQL Overview
SeqLL Incorporated is a life sciences instrumentation and research services company focused on the manufacture of genetic analysis technologies. It offers a True Single Molecule Sequencing (tSMS) platform (a single molecule solution for DNA and RNA sequencing). The company has positioned itself to address gaps left by standard sequencing technologies in RNA transcriptome analysis and specialty DNA analysis. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is headquartered in Billerica, MA.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SQL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SQL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SQL is good value based on its book value relative to its share price (1.52x), compared to the US Diagnostics & Research industry average (4.02x)
P/B vs Industry Valuation
SQL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SQL due diligence checks available for Premium users.
Be the first to know about important SQL news, forecast changes, insider trades & much more!
SQL News
Valuation
SQL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.18x
Industry
31.67x
Market
52.69x
SQL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.52x
Industry
4.02x
SQL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SQL's financial health
Profit margin
Revenue
$0.0
Net Income
-$1.7M
Profit Margin
0%
SQL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SQL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.5M
Liabilities
$4.2M
Debt to equity
1
SQL's short-term assets ($6.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SQL's short-term assets ($6.70M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SQL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.1M
Investing
$2.5M
Financing
$1.5M
SQL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SQL vs Diagnostic & Research Stocks
Seqll Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.